Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal of Child and Adolescent Psychopharmacology
|
June 5, 1999
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases
C N Epperson, D Fasula, S Wasylink, et al.
Journal of Clinical Psychopharmacology
|
October 28, 1998
Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder
M N Potenza, S Wasylink, J G Longhurst, et al.
Archives of General Psychiatry
|
August 2, 2000
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
C J McDougle, C N Epperson, G H Pelton, et al.
Biological Psychiatry
|
August 25, 1999
Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder
J G Longhurst, L L Carpenter, C N Epperson, et al.
The Journal of Clinical Psychiatry
|
November 1, 1995
Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases
C J McDougle, R L Fleischmann, C N Epperson, et al.
Molecular Psychiatry
|
May 3, 2002
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
J H Krystal, G Sanacora, H Blumberg, et al.
Psychological Medicine
|
November 22, 2016
The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale
A Di Florio, K Putnam, M Altemus, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal of Child and Adolescent Psychopharmacology
|
June 5, 1999
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases
C N Epperson, D Fasula, S Wasylink, et al.
Journal of Clinical Psychopharmacology
|
October 28, 1998
Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder
M N Potenza, S Wasylink, J G Longhurst, et al.
Archives of General Psychiatry
|
August 2, 2000
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
C J McDougle, C N Epperson, G H Pelton, et al.
Biological Psychiatry
|
August 25, 1999
Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder
J G Longhurst, L L Carpenter, C N Epperson, et al.
The Journal of Clinical Psychiatry
|
November 1, 1995
Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases
C J McDougle, R L Fleischmann, C N Epperson, et al.
Molecular Psychiatry
|
May 3, 2002
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
J H Krystal, G Sanacora, H Blumberg, et al.
Psychological Medicine
|
November 22, 2016
The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale
A Di Florio, K Putnam, M Altemus, et al.
Page
of 2